"avatrombopag"[nm] - Search Results

Year	Number of Results
2008	1
2009	2
2010	1
2011	1
2012	1
2013	1
2014	2
2015	1
2017	1
2018	13
2019	7
2020	5
2021	13
2022	14
2023	17
2024	5

1

Avatrombopag: A Review in Thrombocytopenia.

Markham A. Markham A. Drugs. 2021 Nov;81(16):1905-1913. doi: 10.1007/s40265-021-01613-y. Epub 2021 Oct 28. Drugs. 2021. PMID: 34709601 Free PMC article. Review.

2

Phase 3 randomised study of avatrombopag, a novel thrombopoietin receptor agonist for the treatment of chronic immune thrombocytopenia.

Jurczak W, Chojnowski K, Mayer J, Krawczyk K, Jamieson BD, Tian W, Allen LF. Jurczak W, et al. Br J Haematol. 2018 Nov;183(3):479-490. doi: 10.1111/bjh.15573. Epub 2018 Sep 7. Br J Haematol. 2018. PMID: 30191972 Free PMC article. Clinical Trial.

3

The structure, function, and clinical use of the thrombopoietin receptor agonist avatrombopag.

Kuter DJ. Kuter DJ. Blood Rev. 2022 May;53:100909. doi: 10.1016/j.blre.2021.100909. Epub 2021 Nov 16. Blood Rev. 2022. PMID: 34815110 Free article. Review.

4

Avatrombopag.

Bussel JB. Bussel JB. Br J Haematol. 2018 Nov;183(3):342-343. doi: 10.1111/bjh.15568. Epub 2018 Oct 23. Br J Haematol. 2018. PMID: 30351482 Free article. No abstract available.

5

Avatrombopag Before Procedures Reduces Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia.

Terrault N, Chen YC, Izumi N, Kayali Z, Mitrut P, Tak WY, Allen LF, Hassanein T. Terrault N, et al. Gastroenterology. 2018 Sep;155(3):705-718. doi: 10.1053/j.gastro.2018.05.025. Epub 2018 May 17. Gastroenterology. 2018. PMID: 29778606 Free article. Clinical Trial.

6

Avatrombopag for chemotherapy-induced thrombocytopenia in patients with non-haematological malignancies: an international, randomised, double-blind, placebo-controlled, phase 3 trial.

Al-Samkari H, Kolb-Sielecki J, Safina SZ, Xue X, Jamieson BD. Al-Samkari H, et al. Lancet Haematol. 2022 Mar;9(3):e179-e189. doi: 10.1016/S2352-3026(22)00001-1. Lancet Haematol. 2022. PMID: 35240074 Clinical Trial.

7

Avatrombopag: First Global Approval.

Shirley M. Shirley M. Drugs. 2018 Jul;78(11):1163-1168. doi: 10.1007/s40265-018-0949-8. Drugs. 2018. PMID: 29995177 Review.

8

Adults with immune thrombocytopenia who switched to avatrombopag following prior treatment with eltrombopag or romiplostim: A multicentre US study.

Al-Samkari H, Jiang D, Gernsheimer T, Liebman H, Lee S, Wojdyla M, Vredenburg M, Cuker A. Al-Samkari H, et al. Br J Haematol. 2022 May;197(3):359-366. doi: 10.1111/bjh.18081. Epub 2022 Feb 18. Br J Haematol. 2022. PMID: 35179784 Free PMC article.

9

Recent progress in ITP treatment.

Rodeghiero F. Rodeghiero F. Int J Hematol. 2023 Mar;117(3):316-330. doi: 10.1007/s12185-022-03527-1. Epub 2023 Jan 9. Int J Hematol. 2023. PMID: 36622549 Review.

10

Avatrombopag for the treatment of immune thrombocytopenia.

Długosz-Danecka M, Zdziarska J, Jurczak W. Długosz-Danecka M, et al. Expert Rev Clin Immunol. 2019 Apr;15(4):327-339. doi: 10.1080/1744666X.2019.1587294. Epub 2019 Mar 8. Expert Rev Clin Immunol. 2019. PMID: 30799645 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

73 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Results by year